Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
108,791,682
-
Share change
-
-3,128,739
-
Total reported value
-
$9,798,327,918
-
Put/Call ratio
-
163%
-
Price per share
-
$90.06
-
Number of holders
-
721
-
Value change
-
-$304,768,029
-
Number of buys
-
249
-
Number of sells
-
396
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2024
As of 31 Dec 2024,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
721 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,791,682 shares.
The largest 10 holders included
BNP PARIBAS FINANCIAL MARKETS, CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, UBS Group AG, WELLS FARGO & COMPANY/MN, and CANADA PENSION PLAN INVESTMENT BOARD.
This page lists
729
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.